drugset / Trial / NCT00154141

Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures

NCT00154141

Phase 3 Completed 150 enrolled Ethicon, Inc. OMRIX Biopharmaceuticals · collab
RandomizedParallel-groupSingle-blind

Summary

A comparison of a fibrin sealant versus manual compression in stopping surgical bleeding during vascular procedures.

Timeline

Start
2005-06
Primary completion
Completion
2006-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Fibrinogen Concentrate Human Protein / enzyme biologic